| PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION |
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION The following tables present parent company only condensed financial information. Condensed Parent Company Only Balance Sheets: | | | | | | | | | | | | | (Dollars in thousands) | December 31, 2025 | | December 31, 2024 | | ASSETS | | | | | Cash and cash equivalents | $ | 10,750 | | | $ | 13,412 | | | Securities - held to maturity | 1,550 | | | 1,876 | | | Investment in bank subsidiary | 1,038,101 | | | 987,466 | | | Investment in non-bank subsidiaries | 281 | | | 191 | | | Other assets | 5,412 | | | 2,869 | | | Total assets | $ | 1,056,094 | | | $ | 1,005,814 | | | LIABILITIES AND EQUITY | | | | | Subordinated notes | $ | 69,879 | | | $ | 69,662 | | | Junior subordinated debentures | 42,991 | | | 42,352 | | | Intercompany payables | 167 | | | 513 | | | Accrued expenses and other liabilities | 1,286 | | | 2,368 | | | Total liabilities | 114,323 | | | 114,895 | | | Stockholders' equity | 941,771 | | | 890,919 | | | Total liabilities and equity | $ | 1,056,094 | | | $ | 1,005,814 | |
Condensed Parent Company Only Statements of Income: | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | (Dollars in thousands) | 2025 | | 2024 | | 2023 | | Interest income | $ | 180 | | | $ | 178 | | | $ | 175 | | | Interest expense | (6,751) | | | (9,347) | | | (9,702) | | | Credit loss (expense) benefit | (277) | | | (301) | | | (746) | | | Other income | 119 | | | 139 | | | 134 | | | Salaries and employee benefits expense | (763) | | | (716) | | | (639) | | | Other expense | (3,186) | | | (3,259) | | | (3,378) | | | Income (loss) before income tax and income from subsidiaries | (10,678) | | | (13,306) | | | (14,156) | | | Income tax (expense) benefit | 2,653 | | | 2,409 | | | 2,944 | | | Dividends from subsidiaries and equity in undistributed subsidiary income | 33,384 | | | 26,987 | | | 52,293 | | | Net income | 25,359 | | | 16,090 | | | 41,081 | | | Dividends on preferred stock | (3,206) | | | (3,206) | | | (3,206) | | | Net income available to common stockholders | $ | 22,153 | | | $ | 12,884 | | | $ | 37,875 | | | Comprehensive income attributable to Parent | $ | 26,735 | | | $ | 15,901 | | | $ | 45,055 | |
Condensed Parent Company Only Statements of Cash Flows: | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | (Dollars in thousands) | 2025 | | 2024 | | 2023 | | Cash flows from operating activities: | | | | | | | Net income | $ | 25,359 | | | $ | 16,090 | | | $ | 41,081 | | | Adjustments to reconcile net income to net cash provided by (used in) operating activities: | | | | | | | Equity in undistributed subsidiary income | (23,384) | | | (3,987) | | | (10,293) | | | Net accretion of securities | (180) | | | (178) | | | (175) | | | Amortization of junior subordinated debentures | 639 | | | 612 | | | 582 | | | Amortization of subordinated notes issuance costs | 217 | | | 484 | | | 878 | | | Stock based compensation | 794 | | | 746 | | | 719 | | | Credit loss expense (benefit) | 277 | | | 301 | | | 746 | | | Change in other assets | (2,543) | | | 61 | | | 1,638 | | | Change in accrued expenses and other liabilities | (1,428) | | | (2,324) | | | (1,127) | | | Net cash provided by (used in) operating activities | (249) | | | 11,805 | | | 34,049 | | | Cash flows from investing activities: | | | | | | | Investment in subsidiaries | (14) | | | 1 | | | (33) | | | Proceeds from maturities, calls, and pay downs of securities held to maturity | 229 | | | 978 | | | 529 | | | | | | | | | | | | | | | Net cash provided by (used in) investing activities | 215 | | | 979 | | | 496 | | | Cash flows from financing activities: | | | | | | | | | | | | | Repayment of subordinated notes | — | | | (39,500) | | | — | | | | | | | | | | | | | | | Dividends on preferred stock | (3,206) | | | (3,206) | | | (3,206) | | | Purchase of treasury stock | (2,227) | | | (3,292) | | | (81,623) | | | Stock option exercises | 320 | | | 413 | | | 144 | | | Proceeds from employee stock purchase plan common stock issuance | 2,485 | | | 2,184 | | | 1,831 | | | Net cash provided by (used in) financing activities | (2,628) | | | (43,401) | | | (82,854) | | | Net increase (decrease) in cash and cash equivalents | (2,662) | | | (30,617) | | | (48,309) | | | Cash and cash equivalents at beginning of period | 13,412 | | | 44,029 | | | 92,338 | | | Cash and cash equivalents at end of period | $ | 10,750 | | | $ | 13,412 | | | $ | 44,029 | |
|